RecallHawk

FENTANYL CITRATE

SPECGX LLC

Summary

FDA approved FENTANYL CITRATE by SPECGX LLC. ANDA (Generic) approval (REMS) on 2022-12-08. TROCHE/LOZENGE, TRANSMUCOSAL.

Details

Source

Drug Approval

External ID

ANDA078907-25

Action Date

2022-12-08

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

FENTANYL CITRATE, TROCHE/LOZENGE, TRANSMUCOSAL. Application: ANDA078907

Company

Context & Analysis

SPECGX LLC has 19 FDA actions in our database, including 2 recalls.

Frequently Asked Questions

How often does SPECGX LLC have FDA actions?

SPECGX LLC has 19 FDA actions in our database, including 2 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA078907-25" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions